argenx to Report Full Year 2022 Financial Results and Fourth Quarter Business Update on March 2, 2023
February 23, 2023 Amsterdam, the Netherlands – argenx (Euronext & Nasdaq: ARGX), a global immunology…
Month: February 2023
BioSenic optimizes statistical analysis for its ongoing ALLOB Phase IIb study for high-risk tibial fractures, requiring fewer patients and completes patient recruitment
Combination of advances in radiological assessments, new scientific insights in fracture healing and updated statistical…
Roche launches two new antibodies to identify key clinical mutations in patients with brain cancer
Recent advances in cancer genomics have deepened the medical community’s understanding of the molecular alterations…
Tudi Selects ThetaRay AI Solution to Monitor Domestic Payments in Mexico
Mexican financial mobile app to integrate AI-powered AML technology for detection of known and unknown…
Apellis Pharmaceuticals Announces Pricing of Public Offering of Common Stock and Pre-Funded Warrants
WALTHAM, Mass., Feb. 22, 2023 (GLOBE NEWSWIRE) — Apellis Pharmaceuticals, Inc., (Nasdaq:APLS), a global biopharmaceutical company…
Shopify Announces Multi-Year Initiative to Transform Partner Program
First phase helps partners earn more and upskill, and introduces new partner events New incentives…
Real Estate Content Marketing & SEO Service Launched by Sebset Digital Agency
Sebset Digital Agency, a digital marketing agency with a focus on real estate agents, has…
Hitachi Energy launches the next-generation TXpert solution to digitalize every transformer
ZURICH, SWITZERLAND, Feb 23, 2023 – (JCN Newswire) – Hitachi Energy, a global technology leader…
Gotion High-Tech Wins Volkswagen Cell Test Lab Qualification
HONG KONG, Feb 23, 2023 – (ACN Newswire) – On February 21, Gotion High-tech was…
Aprea Therapeutics Announces Pricing of $5.5 Million Underwritten Public Offering of Common Stock
DOYLESTOWN, Pa., Feb. 22, 2023 (GLOBE NEWSWIRE) — Aprea Therapeutics, Inc. (Nasdaq: APRE) (“Aprea”, or…
DelphX Announces Non-Brokered Unit Financing
Toronto, Ontario–(Newsfile Corp. – February 22, 2023) – DelphX Capital Markets Inc. (TSXV: DELX) (OTCQB:…
Samsung Electronics Introduces Standardized 5G NTN Modem Technology to Power Smartphone-Satellite Communication
Standardized 5G NTN technology simulated on Samsung’s Exynos Modem 5300; Demonstrates two-way text messaging as…
Eastman Announces Pricing of $500 Million 5.750% Notes due 2033 in Inaugural Green Bond Offering
KINGSPORT, Tenn.–(BUSINESS WIRE)–Eastman Chemical Company (NYSE: EMN) today announced the pricing of its public offering…
Theratechnologies Presents New Tesamorelin Data Demonstrating Improvement of Metabolic Syndrome in People with HIV
Presentation at Conference on Retroviruses and Opportunistic Infections (CROI) demonstrates association between excess visceral abdominal…
Amicus Therapeutics Announces Positive Long-Term Data from Phase 3 Open-label Extension Study of AT-GAA in Late-Onset Pompe Disease at the 19th Annual WORLDSymposium™ 2023
Meaningful and Durable Responses in Key Endpoints of Six-Minute Walk, Forced Vital Capacity for ERT-Naïve…
Jounce Therapeutics Announces Restructuring
CAMBRIDGE, Mass., Feb. 22, 2023 (GLOBE NEWSWIRE) — Jounce Therapeutics, Inc. (Nasdaq: JNCE), a clinical-stage…
Neuronetics to Report Fourth Quarter 2022 Financial and Operating Results and Host Conference Call
MALVERN, Pa., Feb. 22, 2023 (GLOBE NEWSWIRE) — Neuronetics, Inc. (NASDAQ: STIM), a commercial stage…
Denali Therapeutics Announces New Interim Data from DNL310 Phase 1/2 Study for MPS II and DNL126 Preclinical Data for MPS IIIA at WORLDSymposium™
Over 49 weeks of DNL310 (ETV:IDS) treatment in the Phase 1/2 study, positive changes across…
MDxHealth to Present Fourth Quarter and Full Year 2022 Financial Results on March 8, 2023
NEWS RELEASEFEBRUARY 22, 2023, 4:30pm ET/ 22:30 CET Company to Host Conference Call…
Impel Pharmaceuticals Announces Strategic Reprioritization, Continues Focus on Maximizing Trudhesa® Commercial Opportunity
Cost-Saving Measures Eliminate Pipeline Programs and Reduce Headcount by 16 Percent Company will Continue to…